These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16012907)

  • 21. Hereditary motor and sensory neuropathies or Charcot-Marie-Tooth diseases: an update.
    Tazir M; Hamadouche T; Nouioua S; Mathis S; Vallat JM
    J Neurol Sci; 2014 Dec; 347(1-2):14-22. PubMed ID: 25454638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Charcot-Marie-Tooth disorders: past, today and tomorrow].
    Kochański A
    Neurol Neurochir Pol; 2006; 40(4):327-35. PubMed ID: 16967355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proof of genetic heterogeneity in X-linked Charcot-Marie-Tooth disease.
    Huttner IG; Kennerson ML; Reddel SW; Radovanovic D; Nicholson GA
    Neurology; 2006 Dec; 67(11):2016-21. PubMed ID: 17159110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Charcot-Marie-Tooth disease: a clinico-genetic confrontation.
    Barisic N; Claeys KG; Sirotković-Skerlev M; Löfgren A; Nelis E; De Jonghe P; Timmerman V
    Ann Hum Genet; 2008 May; 72(Pt 3):416-41. PubMed ID: 18215208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An epidemiological genetic study of Charcot-Marie-Tooth disease in Western Japan.
    Kurihara S; Adachi Y; Wada K; Awaki E; Harada H; Nakashima K
    Neuroepidemiology; 2002; 21(5):246-50. PubMed ID: 12207153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation analysis of the small heat shock protein 27 gene in chinese patients with Charcot-Marie-Tooth disease.
    Tang B; Liu X; Zhao G; Luo W; Xia K; Pan Q; Cai F; Hu Z; Zhang C; Chen B; Zhang F; Shen L; Zhang R; Jiang H
    Arch Neurol; 2005 Aug; 62(8):1201-7. PubMed ID: 16087758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of symptomatic Charcot-Marie-Tooth disease in Iceland: a study of a well-defined population.
    Gudmundsson B; Olafsson E; Jakobsson F; Lúthvígsson P
    Neuroepidemiology; 2010; 34(1):13-7. PubMed ID: 19893324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive genetic sequence and copy number analysis for Charcot-Marie-Tooth disease in a Canadian cohort of 2517 patients.
    Volodarsky M; Kerkhof J; Stuart A; Levy M; Brady LI; Tarnopolsky M; Lin H; Ainsworth P; Sadikovic B
    J Med Genet; 2021 Apr; 58(4):284-288. PubMed ID: 32376792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The various Charcot-Marie-Tooth diseases.
    Vallat JM; Mathis S; Funalot B
    Curr Opin Neurol; 2013 Oct; 26(5):473-80. PubMed ID: 23945280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Charcot-Marie-Tooth diseases: an update and some new proposals for the classification.
    Mathis S; Goizet C; Tazir M; Magdelaine C; Lia AS; Magy L; Vallat JM
    J Med Genet; 2015 Oct; 52(10):681-90. PubMed ID: 26246519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic spectrum of MCM3AP and its relationship with phenotype of Charcot-Marie-Tooth disease.
    Dong HL; Wei Q; Li JQ; Li HF; Bai G; Ma H; Wu ZY
    J Peripher Nerv Syst; 2020 Jun; 25(2):107-111. PubMed ID: 32319184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Charcot-Marie-Tooth neuropathies: from clinical description to molecular genetics.
    Ionasescu VV
    Muscle Nerve; 1995 Mar; 18(3):267-75. PubMed ID: 7870103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Charcot-Marie-Tooth: are you testing for proteinuria?
    De Rechter S; De Waele L; Levtchenko E; Mekahli D
    Eur J Paediatr Neurol; 2015 Jan; 19(1):1-5. PubMed ID: 25439738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.
    Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO
    Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational analysis of the 5' non-coding region of GJB1 in a Taiwanese cohort with Charcot-Marie-Tooth neuropathy.
    Tsai PC; Chen CH; Liu AB; Chen YC; Soong BW; Lin KP; Yet SF; Lee YC
    J Neurol Sci; 2013 Sep; 332(1-2):51-5. PubMed ID: 23827825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation analysis of PMP22 in Slovak patients with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies.
    Resko P; Radvansky J; Odnogova Z; Baldovic M; Minarik G; Polakova H; Palffy R; Kadasi L
    Gen Physiol Biophys; 2011 Dec; 30(4):379-88. PubMed ID: 22131320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Genetics of peripheral neuropathies and hereditary ataxias].
    Palau F; Sevilla T
    Neurologia; 1995 Dec; 10 Suppl 1():32-43. PubMed ID: 8838557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2).
    Engelfried K; Vorgerd M; Hagedorn M; Haas G; Gilles J; Epplen JT; Meins M
    BMC Med Genet; 2006 Jun; 7():53. PubMed ID: 16762064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurophysiology and molecular genetics of Charcot-Marie-Tooth type 1 neuropathy in Croatian children: follow-up study.
    Barisić N; Mihatov I
    Croat Med J; 2000 Sep; 41(3):306-13. PubMed ID: 10962051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial dysfunction and pathophysiology of Charcot-Marie-Tooth disease involving GDAP1 mutations.
    Cassereau J; Chevrollier A; Gueguen N; Desquiret V; Verny C; Nicolas G; Dubas F; Amati-Bonneau P; Reynier P; Bonneau D; Procaccio V
    Exp Neurol; 2011 Jan; 227(1):31-41. PubMed ID: 20849849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.